Effectiveness of Combining Piperacillin Sodium Tazobactam Sodium and Dexamethasone in the Treatment of Community-Acquired Pneumonia with Fever
Objective To explore the efficacy of combination therapy with piperacillin sodium tazobactam sodium and dexamethasone in patients with community-acquired pneumonia with fever.Methods A total of 86 community-acquired pneumoniafrom patients with fever in Hongquan Hospital of Yangzhou from February 2020 to October 2010 were obiectively selected.They were grouped by thethe different administration methods,they were divided into con-trol group and observation group,with 43 cases in each group.In the control group,piperacillin sodium taazobactam sodium injection,the observation group added dexamethasone injection,to compare the treatment effect,time to symp-tom improvement,level of inflammatory factors and adverse effects.Results Higher efficacy rate in the observation group was 95.35%(41/43)was higher compared to the control group 79.07%(34/43),the difference was statistically significant(χ2=5.108,P<0.05).The improvement time of various symptoms and levels of inflammatory factors in the observation group after treatment were lower than those in the control group,the differences were statistically signifi-cant(all P<0.05).There was no statistically significant difference in the adverse reaction rate ratio between the two groups(P>0.05).Conclusion The addition of dexamethasone to piperacillin sodium tazobactam sodium therapy in pa-tients with community-acquired pneumonia associated with fever improves the therapeutic and reduces the inflamma-tory response,and is worthy of promotion.
万方数据
维普
